Refractory Type I pityriasis rubra pilaris treated with tildrakizumab. Licata G, Gambardella A, Calabrese G, Pagliuca F, et al. Clin Exp Dermatol 2021;46:1594-1595.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Licata G, Gambardella A, Calabrese G, Pagliuca F, et al. Refractory Type I pityriasis rubra pilaris treated with tildrakizumab. Clin Exp Dermatol 2021;46:1594-1595.
PMID: 34101231